Conference
Phase II randomized window of opportunity trial evaluating cytotoxic and immunomodulatory effects of intratumoral INT230-6 in early stage breast cancer: The INVINCIBLE trial.
Authors
Spears M; Hopkins M; Keyhanian K; Robertson S; Liao L; Talebian V; Awan AA; Pond GR; Bartlett J; Bender LH
Volume
41
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Publication Date
June 1, 2023
Name of conference
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
Conference place
IL, Chicago
Conference start date
June 2, 2023
Conference end date
June 6, 2023
Conference proceedings
JOURNAL OF CLINICAL ONCOLOGY
Issue
16
ISSN
0732-183X